Candel Therapeutics, Inc. (CADL) Interest Expense USD 2022 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Candel Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2022 to 2024.
  • Candel Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $646 K, a 6.08% increase year-over-year.
  • Candel Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $2.63 M.
  • Candel Therapeutics, Inc. annual Interest Expense for 2023 was $2.6 M, a 51.9% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.63 M $646 K +$37 K +6.08% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.6 M $673 K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $669 K +$150 K +28.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $644 K +$209 K +48% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $609 K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 $519 K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $435 K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.